Literature DB >> 10664860

Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza Bunge.

D S Lee1, S H Lee, J G Noh, S D Hong.   

Abstract

Cryptotanshinone and dihydrotanshinone I, constituents of a medicinal plant, Salvia miltiorrhiza Bunge, had antibacterial activity against a broad range of Gram positive bacteria. These compounds generated superoxide radicals in Bacillus subtilis lysates. A recombination-deficient mutant strain of B. subtilis was 2- to 8-fold more sensitive than a wild strain, and this hypersensitivity was reduced in the presence of dithiothreitol as an antioxidant. DNA, RNA, and protein syntheses in B. subtilis were non-selectively inhibited by these compounds. These results suggest that superoxide radicals are important in the antibacterial actions of the agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10664860     DOI: 10.1271/bbb.63.2236

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  23 in total

1.  Simplify: A Mass Spectrometry Metabolomics Approach to Identify Additives and Synergists from Complex Mixtures.

Authors:  Lindsay K Caesar; Sabina Nogo; Cassandra N Naphen; Nadja B Cech
Journal:  Anal Chem       Date:  2019-08-15       Impact factor: 6.986

2.  Anti-inflammatory effect of tanshinone I in neuroprotection against cerebral ischemia-reperfusion injury in the gerbil hippocampus.

Authors:  Joon Ha Park; Ok kyu Park; Jeong-Hwi Cho; Bai Hui Chen; In Hye Kim; Ji Hyeon Ahn; Jae-Chul Lee; Bing Chun Yan; Ki-Yeon Yoo; Choong Hyun Lee; In Koo Hwang; Seung-Hae Kwon; Yun Lyul Lee; Moo-Ho Won; Jung Hoon Choi
Journal:  Neurochem Res       Date:  2014-04-24       Impact factor: 3.996

3.  Opportunities and Limitations for Untargeted Mass Spectrometry Metabolomics to Identify Biologically Active Constituents in Complex Natural Product Mixtures.

Authors:  Lindsay K Caesar; Joshua J Kellogg; Olav M Kvalheim; Nadja B Cech
Journal:  J Nat Prod       Date:  2019-03-07       Impact factor: 4.050

4.  Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo.

Authors:  Peipei Luo; Yanqiang Huang; Xudong Hang; Qian Tong; Liping Zeng; Jia Jia; Guoxin Zhang; Hongkai Bi
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

5.  Cryptotanshinone has diverse effects on cell cycle events in melanoma cell lines with different metastatic capacity.

Authors:  Lei Chen; Shi-zhong Zheng; Zhi-guang Sun; Ai-yun Wang; Chen-hu Huang; Neville A Punchard; Shi-le Huang; Xiang Gao; Yin Lu
Journal:  Cancer Chemother Pharmacol       Date:  2010-09-04       Impact factor: 3.333

6.  Cryptotanshinone inhibits chemotactic migration in macrophages through negative regulation of the PI3K signaling pathway.

Authors:  M-J Don; J-F Liao; L-Y Lin; W-F Chiou
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

7.  Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway.

Authors:  Fangyan Zhang; Wenhua Zheng; Rongbiao Pi; Zhengrong Mei; Yingxia Bao; Jie Gao; Wenjie Tang; Shaorui Chen; Peiqing Liu
Journal:  Exp Brain Res       Date:  2008-10-21       Impact factor: 1.972

8.  Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.

Authors:  Jin Zeng; Yu-Juan Fan; Bo Tan; Hui-Zong Su; Yue Li; Lin-Lin Zhang; Jian Jiang; Fu-Rong Qiu
Journal:  Acta Pharmacol Sin       Date:  2018-02-08       Impact factor: 6.150

9.  Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cryptotanshinone.

Authors:  Haihua Feng; Hua Xiang; Jiyu Zhang; Guowen Liu; Na Guo; Xuelin Wang; Xiuping Wu; Xuming Deng; Lu Yu
Journal:  J Biomed Biotechnol       Date:  2009-08-23

Review 10.  Tanshinones: sources, pharmacokinetics and anti-cancer activities.

Authors:  Yong Zhang; Peixin Jiang; Min Ye; Sung-Hoon Kim; Cheng Jiang; Junxuan Lü
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.